Lixisenatide is a once-daily injectable GLP-1 receptor agonist for the treatment of diabetes type II.
The growth of the global lixisenatide market is driven by increase in prevalence diabetes and surge in overweight populace.
Moreover, unhealthy urban lifestyle and increase number of fast food eating populace susceptible to sudden weight gain are expected to boost the market growth.
However, number of limited manufacturers and distribution channels is anticipated to impede the market growth.
The global Lixisenatide market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Lixisenatide volume and value at global level, regional level and company level. From a global perspective, this report represents overall Lixisenatide market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Lixisenatide in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Lixisenatide manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.
The following manufacturers are covered:
Zealand Pharma
Sanofi-Aventis
...
Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India
Segment by Type
Industrial Grade
Pharmaceutical Grade
Segment by Application
Hospital
Clinic
Medical center
Others
Summary:
Get latest Market Research Reports on Lixisenatide. Industry analysis & Market Report on Lixisenatide is a syndicated market report, published as Global Lixisenatide Market Professional Survey Report 2019. It is complete Research Study and Industry Analysis of Lixisenatide market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.